Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

Enhancing immune response can improve cancer treatment effectiveness.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A small 3D skin model helps study how immune cells move in the skin.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

The study identified key immune cell differences between mild and severe alopecia areata.